8-K: Kenvue Announces CEO Transition and Strategic Review Amidst Preliminary Q2 Sales Decline

Kenvue Inc. announced a leadership transition with the departure of CEO Thibaut Mongon and the appointment of Kirk Perry as interim CEO, alongside a comprehensive strategic review and preliminary second-quarter 2025 financial results showing a sales decline.

Summary

• Thibaut Mongon ceased serving as Chief Executive Officer and stepped down from the Board of Directors, effective July 14, 2025.
• Kirk L. Perry, a current Kenvue director, has been appointed Interim Chief Executive Officer, effective July 14, 2025, while the Board undertakes a search for a permanent CEO.
• The Board of Directors has initiated a comprehensive review of strategic alternatives, overseen by a newly established Strategic Review Committee.
• Preliminary net sales for the second quarter ended June 29, 2025, decreased by 4.0% compared to the prior year.
• Preliminary organic sales for the second quarter ended June 29, 2025, decreased by 4.2% compared to the prior year.
• Preliminary diluted earnings per share for the second quarter ended June 29, 2025, are estimated to be between $0.21 and $0.22.
• Preliminary adjusted diluted earnings per share for the second quarter ended June 29, 2025, are estimated to be between $0.28 and $0.29.
• Full second-quarter financial results and revised financial guidance for full year 2025 will be released on August 7, 2025, with an accompanying earnings call.

Sentiment

Score: 4

Explanation: The document presents significant negative preliminary financial results (sales decline) and a CEO transition, which often signals underlying issues. While a strategic review is a positive step towards addressing challenges, its outcome is uncertain. The interim CEO appointment provides stability but highlights the lack of a permanent leader.

Positives

• Appointment of Kirk Perry, a seasoned consumer products and brand strategist with over 30 years of global consumer-packaged goods, technology, and business transformation experience, as Interim CEO.
• Initiation of a comprehensive strategic review to consider a broad range of potential alternatives, including optimizing the Company's brand portfolio, improving execution, and enhancing operating performance to accelerate profitable growth and unlock inherent value.
• The Board and the Strategic Review Committee are being advised by reputable financial and consulting firms, Centerview Partners and McKinsey & Company.
• Kirk Perry's interim compensation package includes an annualized base salary of $1,250,000, eligibility for a performance-based cash bonus of up to $1,500,000, and a one-time equity grant with an aggregate value of $5,000,000.

Negatives

• Preliminary net sales for the second quarter ended June 29, 2025, decreased by 4.0%.
• Preliminary organic sales for the second quarter ended June 29, 2025, decreased by 4.2%.
• The departure of CEO Thibaut Mongon, classified as a 'separation without cause,' indicates a significant and potentially abrupt leadership change.

Risks

• The outcome and timing of the strategic review process are uncertain and may be suspended or modified at any time.
• The Company may decide not to undertake a strategic alternative following the Board's strategic review process.
• Inability to consummate any proposed strategic alternative resulting from the strategic review due to market, regulatory, and other factors.
• Potential for disruption to the Company's business resulting from the strategic review process.
• Potential adverse effects on the Company's stock price from the announcement, suspension, or consummation of the strategic review process and its results.
• Inability to execute on the Company's business development strategy.
• Inflation and other economic factors, such as interest rate and currency exchange rate fluctuations, as well as existing or proposed tariffs and other constraints on trade.
• Ability to successfully manage local, regional, or global economic volatility, including reduced market growth rates.
• Ability to generate sufficient income and cash flow to allow the Company to effect any expected share repurchases and dividend payments.
• Ability to maintain satisfactory credit ratings and access capital markets, which could adversely affect liquidity, capital position, and borrowing costs.
• Competition, including technological advances, new products, and intellectual property attained by competitors.
• Challenges inherent in new product research and development.
• Uncertainty of commercial success for new and existing products and digital capabilities.
• Challenges to intellectual property protections including counterfeiting.
• Ability of the Company to successfully execute strategic plans, including Our Vue Forward and other restructuring or cost-saving initiatives.
• Impact of business combinations and divestitures, including any ongoing or future transactions.
• Manufacturing difficulties or delays, internally or within the supply chain.
• Product efficacy or safety concerns resulting in product recalls or regulatory action.
• Significant adverse litigation or government action, including related to product liability claims.
• Changes to applicable laws and regulations and other requirements imposed by stakeholders.
• Changes in behavior and spending patterns of consumers.
• Natural disasters, acts of war, or terrorism, catastrophes, or epidemics, pandemics, or other disease outbreaks.
• Financial instability of international economies and legal systems and sovereign risk.
• Inability to realize the benefits of the separation from the Company's former parent, Johnson & Johnson, and the risk of disruption or unanticipated costs in connection with the separation.

Future Outlook

Kenvue plans to release its full second-quarter 2025 financial results and revise its full-year 2025 outlook on August 7, 2025. The Board's strategic review is ongoing and will consider a broad range of potential alternatives, including optimizing the brand portfolio, improving execution, and enhancing operating performance to accelerate profitable growth and unlock inherent value. The Company plans to update shareholders as the strategic review progresses.

Management Comments

• "The actions announced today are to ensure we have the right talent, brand portfolio and operational foundation to fully capitalize on those strengths, accelerate profitable growth and best position the Company for future success." Larry Merlo, Kenvue's Chair of the Board.
• "The Boards strategic review is underway, and we are considering a broad range of potential alternatives, including ways to simplify the Companys portfolio and how it operates." Larry Merlo.
• "We are confident that the steps we are taking put Kenvue on the right path to deliver both nearand long-term value creation for shareholders." Larry Merlo.
• "We are very pleased to have a leader of Kirks caliber and experience step into the role of Interim CEO to lead Kenvue during this important time." Larry Merlo.
• "On behalf of the Board, I want to thank Thibaut for his oversight in establishing Kenvue as a standalone company and for his commitment to the organization throughout his tenure." Larry Merlo.
• "I have seen firsthand Kenvues many strengths and share the Boards confidence in the Companys growth and value creation opportunities." Kirk Perry.
• "As interim CEO, I am excited to leverage my decades of experience leading businesses across the consumer and technology industries and work with the Board and leadership team to put the business on the strongest footing to deliver on Kenvues full potential and realize our goal of top-tier financial performance." Kirk Perry.

Industry Context

Kenvue operates in the consumer health sector, a segment often characterized by stable demand but also intense competition and the need for continuous innovation and brand management. The strategic review, including portfolio optimization, suggests the company is adapting to market dynamics and seeking to enhance competitiveness and profitability, a common trend among large CPG companies facing evolving consumer preferences and supply chain pressures. The appointment of an interim CEO with strong CPG and technology experience (Kirk Perry from Circana/Google/P&G) indicates a focus on leveraging data, analytics, and digital transformation, which are critical for modern consumer businesses.

Comparison to Industry Standards

• The document does not provide specific comparable companies, projects, or results to benchmark Kenvue's preliminary Q2 performance against.
• The reported preliminary net sales decline of 4.0% and organic sales decline of 4.2% would need to be compared against the average growth rates of major consumer health or CPG peers (e.g., Procter & Gamble, Colgate-Palmolive, Unilever, Haleon, Reckitt Benckiser) for the same period to assess relative performance. Without these benchmarks, a direct comparison is not possible from the document.

Management Changes

Corporate Governance

Related Party Transactions

• Kenvue paid Circana, Inc. approximately $7.6 million in 2024 for consumer data, analytics, and insights services. Kirk L. Perry was president and CEO of Circana until December 2024 and is currently a director of Circana. These services were provided on an arms-length basis, and Mr. Perry did not have a role in Kenvue's decision-making regarding these services.

Stakeholder Impact

• Shareholders: Significant impact due to CEO transition, strategic review (potential for value unlock or disruption), and preliminary negative financial results. The strategic review aims to accelerate profitable growth and unlock inherent value.
• Employees: Leadership change and potential strategic alternatives (e.g., portfolio optimization, operational enhancements) could lead to organizational restructuring or changes in roles.
• Customers: No direct immediate impact mentioned, but strategic review could lead to changes in brand focus or product offerings in the long term.
• Suppliers: No direct immediate impact mentioned, but operational enhancements or portfolio changes from the strategic review could affect supplier relationships in the long term.
• Creditors: No direct immediate impact mentioned, but the strategic review and financial performance could influence credit ratings and borrowing costs in the long term.

Next Steps

• The Board will undertake a search to identify Kenvue's next permanent Chief Executive Officer.
• Kenvue will release its full second-quarter financial results on August 7, 2025.
• Kenvue will revise its financial guidance for full year 2025 on August 7, 2025.
• Kenvue will hold its second-quarter earnings call on August 7, 2025.
• The Strategic Review Committee will oversee the ongoing strategic review process.
• The Company plans to update shareholders as the strategic review progresses.

Key Dates

Recommendation

Keywords

Kenvue, KVUE, SEC filing, 8-K, CEO transition, strategic review, preliminary financial results, consumer health, CPG, corporate governance, risk management, Q2 2025 earnings, leadership change, portfolio optimization, consumer data, analytics